Annual EBIT
-$378.94 M
-$143.34 M-60.84%
December 31, 2024
Summary
- As of March 9, 2025, RNA annual earnings before interest & taxes is -$378.94 million, with the most recent change of -$143.34 million (-60.84%) on December 31, 2024.
- During the last 3 years, RNA annual EBIT has fallen by -$260.88 million (-220.99%).
- RNA annual EBIT is now -3509.60% below its all-time high of -$10.50 million, reached on December 31, 2018.
Performance
RNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$120.99 M
-$22.86 M-23.29%
December 31, 2024
Summary
- As of March 9, 2025, RNA quarterly earnings before interest & taxes is -$120.99 million, with the most recent change of -$22.86 million (-23.29%) on December 31, 2024.
- Over the past year, RNA quarterly EBIT has dropped by -$22.86 million (-23.29%).
- RNA quarterly EBIT is now -5457.65% below its all-time high of -$2.18 million, reached on March 31, 2019.
Performance
RNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$378.94 M
-$54.25 M-16.71%
December 31, 2024
Summary
- As of March 9, 2025, RNA TTM earnings before interest & taxes is -$378.94 million, with the most recent change of -$54.25 million (-16.71%) on December 31, 2024.
- Over the past year, RNA TTM EBIT has dropped by -$54.25 million (-16.71%).
- RNA TTM EBIT is now -17306.38% below its all-time high of -$2.18 million, reached on March 31, 2019.
Performance
RNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.8% | -23.3% | -16.7% |
| 3 y3 years | -221.0% | -23.3% | -16.7% |
| 5 y5 years | -2084.4% | -23.3% | -16.7% |
RNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -221.0% | at low | -251.1% | at low | -221.0% | at low |
| 5 y | 5-year | -2084.4% | at low | -1914.2% | at low | -2084.4% | at low |
| alltime | all time | -3509.6% | at low | -5457.6% | at low | <-9999.0% | at low |
Avidity Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$378.94 M(+60.8%) | -$120.99 M(+23.3%) | -$378.94 M(+16.7%) |
| Sep 2024 | - | -$98.13 M(+18.8%) | -$324.69 M(+13.9%) |
| Jun 2024 | - | -$82.63 M(+7.0%) | -$285.18 M(+11.8%) |
| Mar 2024 | - | -$77.19 M(+15.6%) | -$255.19 M(+8.3%) |
| Dec 2023 | -$235.60 M(+31.7%) | -$66.74 M(+13.8%) | -$235.60 M(+6.1%) |
| Sep 2023 | - | -$58.63 M(+11.4%) | -$222.08 M(+6.6%) |
| Jun 2023 | - | -$52.63 M(-8.6%) | -$208.38 M(+3.1%) |
| Mar 2023 | - | -$57.60 M(+8.2%) | -$202.05 M(+12.9%) |
| Dec 2022 | -$178.91 M(+51.6%) | -$53.23 M(+18.5%) | -$178.91 M(+8.9%) |
| Sep 2022 | - | -$44.93 M(-3.0%) | -$164.24 M(+10.5%) |
| Jun 2022 | - | -$46.30 M(+34.4%) | -$148.59 M(+15.5%) |
| Mar 2022 | - | -$34.46 M(-10.6%) | -$128.65 M(+9.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$118.05 M(+167.4%) | -$38.55 M(+31.6%) | -$118.05 M(+23.3%) |
| Sep 2021 | - | -$29.28 M(+11.0%) | -$95.78 M(+22.9%) |
| Jun 2021 | - | -$26.37 M(+10.5%) | -$77.94 M(+25.7%) |
| Mar 2021 | - | -$23.86 M(+46.6%) | -$62.00 M(+40.4%) |
| Dec 2020 | -$44.15 M(+154.5%) | -$16.27 M(+42.3%) | -$44.15 M(+30.1%) |
| Sep 2020 | - | -$11.44 M(+9.7%) | -$33.93 M(+22.5%) |
| Jun 2020 | - | -$10.43 M(+73.5%) | -$27.70 M(+30.8%) |
| Mar 2020 | - | -$6.01 M(-0.9%) | -$21.18 M(+22.1%) |
| Dec 2019 | -$17.35 M(+65.2%) | -$6.06 M(+16.5%) | -$17.35 M(+53.7%) |
| Sep 2019 | - | -$5.21 M(+33.5%) | -$11.28 M(+85.7%) |
| Jun 2019 | - | -$3.90 M(+79.2%) | -$6.08 M(+179.2%) |
| Mar 2019 | - | -$2.18 M | -$2.18 M |
| Dec 2018 | -$10.50 M | - | - |
FAQ
- What is Avidity Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Avidity Biosciences?
- What is Avidity Biosciences annual EBIT year-on-year change?
- What is Avidity Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Avidity Biosciences?
- What is Avidity Biosciences quarterly EBIT year-on-year change?
- What is Avidity Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Avidity Biosciences?
- What is Avidity Biosciences TTM EBIT year-on-year change?
What is Avidity Biosciences annual earnings before interest & taxes?
The current annual EBIT of RNA is -$378.94 M
What is the all time high annual EBIT for Avidity Biosciences?
Avidity Biosciences all-time high annual earnings before interest & taxes is -$10.50 M
What is Avidity Biosciences annual EBIT year-on-year change?
Over the past year, RNA annual earnings before interest & taxes has changed by -$143.34 M (-60.84%)
What is Avidity Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of RNA is -$120.99 M
What is the all time high quarterly EBIT for Avidity Biosciences?
Avidity Biosciences all-time high quarterly earnings before interest & taxes is -$2.18 M
What is Avidity Biosciences quarterly EBIT year-on-year change?
Over the past year, RNA quarterly earnings before interest & taxes has changed by -$22.86 M (-23.29%)
What is Avidity Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of RNA is -$378.94 M
What is the all time high TTM EBIT for Avidity Biosciences?
Avidity Biosciences all-time high TTM earnings before interest & taxes is -$2.18 M
What is Avidity Biosciences TTM EBIT year-on-year change?
Over the past year, RNA TTM earnings before interest & taxes has changed by -$54.25 M (-16.71%)